Alive Israel Healthtech Fund - aVenture Asset Manager Research
Location
Tel Aviv, Tel Aviv District, IL
Founded
2020
ALIVE Israel HealthTech Fund focuses on mid-to-late stage investments in the healthtech sector. The fund targets promising Israeli healthtech companies, typically investing in Series A to Series C rounds. ALIVE aims to provide capital-efficient investments with high reward potential and relatively low risk, leveraging its exclusive ecosystem to accelerate growth.
Notable portfolio companies include Cynerio, a healthcare IoT security platform, and Medisafe, a digital therapeutics company. The fund's investment philosophy centers on bringing advanced technologies to patient care and driving long-term growth in Israel's healthtech industry. ALIVE offers value-add services through its ecosystem connections, supporting portfolio companies in realizing their potential and impact in the healthcare sector.
Alive Israel Healthtech Fund - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies4
Current Portfolio Count4
Top Investment Stages
Series A2 (50.0%)
Series B1 (25.0%)
Series C1 (25.0%)
Stage Mix
Series A 50%Series B 25%Series C 25%
Concentration shown as share of disclosed investments by stage.
